Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease . VER. 2025;8(9s):230-236. doi:10.64149/J.Ver.8.9s.230-236